BANK OF AMERICA CORP /DE/ - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 39 filers reported holding ENTRADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$368,835
+11.7%
23,344
+7.0%
0.00%
Q2 2023$330,324
-32.5%
21,818
-35.4%
0.00%
Q1 2023$489,680
+583.9%
33,771
+537.7%
0.00%
Q4 2022$71,602
+13.7%
5,296
+33.5%
0.00%
Q3 2022$63,000
-60.1%
3,966
-69.5%
0.00%
Q2 2022$158,000
-19.4%
12,991
-37.8%
0.00%
Q1 2022$196,000
-49.9%
20,871
-8.6%
0.00%
Q4 2021$391,00022,8420.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$64,173,86826.74%
5AM Venture Management, LLC 4,408,379$63,921,49616.35%
72 Investment Holdings, LLC 509,023$7,380,8333.50%
StepStone Group LP 761,277$11,038,5172.05%
TCG Crossover Management, LLC 584,955$8,481,8481.65%
Redmile Group, LLC 1,831,608$26,558,3161.15%
Nan Fung Group Holdings Ltd 73,582$1,066,9390.73%
Baker Brothers Advisors 4,865,819$70,554,3760.38%
CHI Advisors LLC 56,374$817,4230.22%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,522,5000.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders